Citigroup Reiterates “Buy” Rating for DexCom (NASDAQ:DXCM)

DexCom (NASDAQ:DXCM – Get Free Report)‘s stock had its “buy” rating reissued by analysts at Citigroup in a research report issued to clients and investors on Thursday, Marketbeat.com reports. They presently have a $102.00 price objective on the medical device company’s stock, up from their prior price objective of $82.00. Citigroup’s target price points to […]

May 24, 2025 - 08:36
 0
Citigroup Reiterates “Buy” Rating for DexCom (NASDAQ:DXCM)
DexCom (NASDAQ:DXCM – Get Free Report)‘s stock had its “buy” rating reissued by analysts at Citigroup in a research report issued to clients and investors on Thursday, Marketbeat.com reports. They presently have a $102.00 price objective on the medical device company’s stock, up from their prior price objective of $82.00. Citigroup’s target price points to […]